Changing Healthcare Worldwide

Stay current with the latest press releases

09/20/2016
Transdermal Delivery Solutions & ALZYN Announce License for HypoSpray Delivery of Alzheimers Therapy

12/07/2015
Transdermal Delivery Solutions Announces Commencement of Clinical Trials of Hormone Replacement Technologies Testagen HypoSpray

08/07/2013
CBS 12 NEWS SPOTLIGHT ON TDSC

08/02/2013
WPTV 5 SHOWCASES TDSC TECHNOLOGY

07/30/2013
TDSC RECEIVES FDA APPROVAL TO BEGIN PIVOTAL CLINICAL TRIALS OF TESTAGEN

06/13/2013
TESTAGEN TDS NEW DRUG APPLICATION FILED WITH FDA

05/31/2013
DRUG DEVELOPMENT & DELIVERY ARTICLE ON TDSC

05/15/2013
DR HOWARD MAIBACH HONORED WITH MASTER DERMATOLOGIST AWARD

02/20/2013
TDS SUCCESSFULLY COMPLETES DERMAL TOXICITY EVALUATION

10/10/2012
TRANSDERMAL DELIVERY SOLUTIONS OPENS NEW HEADQUARTERS IN PALM BEACH GARDENS

07/25/2012
TESTAGEN TDS FUNDED FOR TESTING

04/25/2009
TDS® TESTOSTERONE EXCEEDS ANDROGEL® OUTCOMES

04/05/2008
TDSC HAS SUCCESSFUL PRE-IND MEETING FOR TDS® TESTOSTERONE

04/05/2008
TRANSDERMAL ANNOUNCES SUCCESSFUL DELIVERY OF DIAZEPAM THROUGH INTACT SKIN

06/15/2007
TRANSDERMAL TECHNOLOGIES WINS 3RD PATENT AWARD

07/19/2006
GOVERNOR BUSH RECOGNIZED AT RECEPTION SPONSORED BY TDSC AND THE WILLIAM HARVEY INSTITUTE

01/30/2006
TDS®-LICODAINE RECEIVES 2ND PEER-REVIEWED PUBLICATION

09/10/2004
TDS® METHOD PATENT IS PUBLISHED

09/05/2002
TDS® PATENTS PUBLISHED

02/05/2002
THERAPEUTIC OUTCOME CONFIRMED FOR TRANSDERMAL IBUPROFEN

11/25/2001
FURTHER PRE-CLINICAL RESULTS ON TDS® IBUPROFEN

12/20/2000
IN VITRO DATA CONFIRMS DELIVERY OF MORPHINE

11/01/1999
NEW PATCHLESS TRANSDERMAL DELIVERY SYSTEM PROVEN FOR TESTOSTERONE

10/15/1999
ANTI-NEOVASCULAR SUCCESSFULLY DELIVERED WITH NEW PATCHLESS TRANSDERMAL SYSTEM